AML Or Acute Myeloid Leukemia Patients With IDH2 Mutations Get New FDA Approved Drug, Idhifa, For Treatment Medicine & Technology Aug 03, 2017 The FDA has recently approved a new drug Idhifa to treat the AML patients with the IDH2 mutations.
Double-Jointedness Associated With Greater Long COVID Risk, Study Reveals; Findings Could Help Shed Light on Persisting COVID-19 Symptoms, Treatment
SPACE UAP Mystery: India Law Enforcers Report UFO Sightings Over Nuclear Plants, With One Having Bizarre Zigzag Movements
SPACE Driving Hazard Alert: Scientists Warn of Potential Surge in Fatal Car Crashes During April's Total Solar Eclipse
SPACE How to Know if Your Solar Glasses Are Legit Not Counterfeit Ahead of the Anticipated Total Eclipse?
SPACE Dark Matter May Produce Exploding Stars Powered by Weakly Interacting Massive Particles, Study Reveals